GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,425.50p
   
  • Change Today:
    -3.00p
  • 52 Week High: 1,778.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,100.76m
  • Volume: 6,000,152
  • Market Cap: £58,456m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK's COPD treatment approved by FDA

By Benjamin Chiou

Date: Friday 23 May 2025

(Sharecast News) - Pharma group GSK has announced that US regulators have approved for use its Nucala treatment for adults with chronic obstructive pulmonary disease (COPD) following positive results from phase III trials.

GSK's blood cancer treatment approved in Japan

By Benjamin Chiou

Date: Monday 19 May 2025

(Sharecast News) - GSK's Blenrep treatment has been approved by Japanese regulators when in combination for relapsed or refractory multiple myeloma, marking the second major approval of its kind for the drug, with more expected in 2025.

London close: Stocks finish choppy week in the black

By Josh White

Date: Friday 16 May 2025

(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.

GSK buys Boston's developmental liver disease dr... 14-May-2025 ShareCast
Pharma stocks slide as Trump threatens price cut... 12-May-2025 ShareCast
Sunday newspaper round-up: US-China, Aerospace, ... 11-May-2025 ShareCast
London close: FTSE snaps 16-day win streak ahead... 07-May-2025 ShareCast
GSK, AstraZeneca slide after FDA unveils new vac... 07-May-2025 ShareCast
GSK's Nucala delivers positive outcomes in publi... 01-May-2025 ShareCast
London close: Stocks finish higher as US economy... 30-Apr-2025 ShareCast
GSK confirms guidance after strong first quarter 30-Apr-2025 ShareCast
Two GSK vaccines get US CDC recommendations 17-Apr-2025 ShareCast
London close: Stocks fall as China retaliates to... 09-Apr-2025 ShareCast
London close: Stocks slide in global reaction to... 03-Apr-2025 ShareCast
UK pharma stocks avoid selloff 03-Apr-2025 ShareCast
EMA accepts GSK's application to expand Nucala use 24-Mar-2025 ShareCast
FDA to review GSK's depemokimab 03-Mar-2025 ShareCast
London close: Stocks little changed after UK dat... 21-Feb-2025 ShareCast
GSK seen as potential target for activist invest... 21-Feb-2025 ShareCast
London close: Stocks slip as US jobless claims r... 20-Feb-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,425.50p
Change Today -3.00p
% Change -0.21 %
52 Week High 1,778.00p
52 Week Low 1,264.00p
Volume 6,000,152
Shares Issued 4,100.76m
Market Cap £58,456m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.14% below the market average39.14% below the market average39.14% below the market average39.14% below the market average39.14% below the market average
10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average
Price Trend
0.94% below the market average0.94% below the market average0.94% below the market average0.94% below the market average0.94% below the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Income
73.53% above the market average73.53% above the market average73.53% above the market average73.53% above the market average73.53% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 23-May-2025

Time Volume / Share Price
15:11 0 @ 1,424.00p
15:11 0 @ 1,424.00p
14:49 7 @ 1,424.00p
14:49 7 @ 1,424.50p
16:52 360 @ 1,425.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page